頻現利好!聯合醫務(0722.HK)暴漲超20%創逾4個月新高
格隆匯6月3日丨近期表現強勢的聯合醫務(0722.HK)今日盤中再度大肆拉昇,一度漲21.57%報1.24港元,股價創今年1月底以來新高,較5月中旬的最低位0.65港元反彈超90%,市值9.6億港元。公司是香港及澳門領先的醫療保健服務提供商,在國內也是首家擁有線上線下雙語實時遠程醫療服務的提供商,並擁有中國內地的互聯網醫院牌照。公司近期頻現利好,多名股東在5月份進行了增持操作;另外,公司在3月份積極推進了一項收購計劃,佈局MRI市場。進一步瞭解詳情可點擊下列鏈接。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.